

Duromine has been the go-to weight loss pill in Singapore for decades. Walk into most GP clinics asking about weight loss medication and Duromine is what you will get. But the landscape has shifted. GLP-1 medications like Ozempic (semaglutide) have arrived with clinical data showing significantly more weight loss, and the question many Singaporeans are now asking is whether Duromine is still the right choice.
The honest answer: it depends. Duromine and Ozempic work through completely different mechanisms, suit different situations, and come with different trade-offs. Neither is universally "better." This article compares them head-to-head so you can have a more informed conversation with your doctor about which one fits your goals, health profile, and budget.
Duromine is the brand name for phentermine, a sympathomimetic amine that has been used for weight loss since its FDA approval in 1959. It is one of the oldest weight loss medications still in use.
Mechanism: Phentermine stimulates the release of norepinephrine (adrenaline) in the brain, which suppresses appetite and increases alertness and energy. It is essentially a stimulant that reduces hunger by activating the sympathetic nervous system, the same "fight or flight" system that kills your appetite when you are nervous or stressed.
How it feels: Most patients describe feeling less hungry, more energetic, and more focused. The appetite suppression is noticeable from the first dose. Some patients compare it to having several cups of strong coffee.
Duration of use: Duromine is approved for short-term use only, typically up to 12 weeks. This is a hard limit. Beyond 12 weeks, the risks increase and the benefits tend to diminish as your body builds tolerance to the stimulant effect.
Available forms in Singapore: Duromine (slow-release capsules) and Panbesy (immediate-release), in 15 mg and 30 mg doses.
Typical weight loss: Clinical data shows approximately 5-10% body weight loss over a short treatment course.
Ozempic is the brand name for semaglutide, a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces after eating. Semaglutide mimics this hormone at much higher levels.
Mechanism: Semaglutide activates GLP-1 receptors in the brain's hypothalamus, which regulates appetite and satiety. It reduces hunger at a biological level, slows gastric emptying (so food stays in your stomach longer), and improves insulin sensitivity. Unlike Duromine, it does not stimulate the sympathetic nervous system.
How it feels: Patients typically describe feeling naturally less interested in food. The experience is less about a stimulant "boost" and more about food noise going quiet. You still eat. You just think about food less and feel satisfied sooner.
Duration of use: Semaglutide can be used long-term. There is no 12-week limit. Clinical trials have tracked patients for up to 104 weeks (STEP 5), and many doctors prescribe it as ongoing treatment for chronic weight management.
Available forms in Singapore: Ozempic (injectable, weekly), Wegovy (injectable, weekly, higher dose for weight loss), and Rybelsus (oral tablet, daily). For a full comparison, see our guide on Ozempic, Wegovy, and Mounjaro.
Typical weight loss: The STEP 1 trial (Wilding et al., NEJM 2021) showed 14.9% body weight loss at 68 weeks. 86.4% of participants lost at least 5%, and 50.5% lost at least 15%.
| Factor | Duromine (phentermine) | Ozempic (semaglutide) |
|---|---|---|
| Mechanism | Stimulant (norepinephrine release) | Hormonal (GLP-1 receptor activation) |
| Average weight loss | 5-10% | 14.9% (STEP 1 trial) |
| Duration of use | Max 12 weeks | Long-term (no limit) |
| Administration | Daily oral capsule | Weekly injection or daily tablet |
| Onset of effect | Immediate (day 1) | Gradual (weeks 4-8) |
| Common side effects | Insomnia, dry mouth, increased heart rate, restlessness | Nausea, reduced appetite, constipation, diarrhoea |
| Serious risks | Raised blood pressure, cardiovascular strain | Rare: pancreatitis, gallbladder events |
| Cardiovascular | Contraindicated in CVD | Neutral to beneficial (SELECT trial) |
| Cost in Singapore | $90-150/month | $350-650/month |
| Tolerance risk | High (effect diminishes over weeks) | Low (consistent over months) |
| Weight regain after stopping | Common and rapid | Gradual (two-thirds regain within 1 year per STEP 1 extension) |
| Best for | Short-term appetite suppression, lower budget | Significant sustained weight loss, long-term management |
The decision between Duromine and GLP-1 treatment is not simply about which one is "stronger." Your doctor weighs several clinical factors.
Cardiovascular health usually comes first. Duromine (phentermine) is a sympathomimetic, meaning it raises heart rate and blood pressure. It is contraindicated in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, or a history of stroke. Semaglutide, by contrast, has shown cardiovascular benefits. The SELECT trial (Lincoff et al., NEJM 2023) demonstrated a 20% reduction in major cardiovascular events (hazard ratio 0.80) in patients taking semaglutide. If you have any heart-related conditions, Duromine is off the table.
How much weight you need to lose matters too. For patients who need to lose 5-8 kg, Duromine's short-term appetite suppression may be sufficient. For patients who need to lose 10-20+ kg, the 12-week limit of Duromine becomes a real constraint. GLP-1 medications produce larger, sustained weight loss over months to years.
Your broader medical history plays a role. Anxiety disorders, insomnia, and a history of substance abuse are relative contraindications for Duromine due to its stimulant properties. GLP-1 medications do not carry these risks. Conversely, patients with a personal or family history of medullary thyroid carcinoma should not take GLP-1 medications.
Budget is a legitimate consideration. Duromine is significantly cheaper ($90-150/month vs $350-650/month for GLP-1). If budget is the primary constraint, Duromine provides short-term results at a lower cost. But consider the total cost: a 12-week Duromine course that results in weight regain may cost more in the long run than sustained GLP-1 treatment that keeps the weight off. See our full breakdown of GLP-1 treatment costs in Singapore.
And if you have already tried Duromine and regained the weight, that is useful information for your doctor. Many patients come to GLP-1 treatment after Duromine did not produce lasting results.
Your doctor will review all of these factors during a consultation. Read about what doctors assess before prescribing.
Yes. Switching from Duromine to GLP-1 treatment is common in Singapore, and your doctor can manage the transition.
The most common reasons patients switch: Duromine's effect faded after a few weeks, weight came back after the 12-week course ended, or side effects like insomnia or racing heart made Duromine intolerable.
The transition is straightforward. Duromine is typically stopped before starting a GLP-1 medication. There is no overlap period — combining a stimulant with GLP-1 has not been studied and most doctors would not prescribe both at once. Your doctor will usually allow a washout period before starting semaglutide.
One thing to expect: Duromine's appetite suppression stops almost immediately when you stop taking it. GLP-1 medications take 4-8 weeks to reach therapeutic levels due to the dose titration schedule. There may be a gap where your appetite returns to baseline before the GLP-1 takes full effect. Your doctor will prepare you for this and may suggest strategies to manage it.
Thinking about switching from Duromine to GLP-1 treatment?
Book Consultation
Cost is a real factor in this decision, and it is worth being honest about the numbers.
Duromine typically costs $90-150 per month at a GP clinic, including the consultation fee. A 12-week course runs roughly $270-450 total. Some GP clinics charge separately for the consultation ($30-50) and the medication.
GLP-1 medications cost $350-650 per month at Trimly, with all-in pricing that includes medication, doctor consultations, and unlimited follow-ups. Over 6 months, that is $2,100-3,900. Over 12 months, $4,200-7,800.
Duromine is cheaper per month. But the clinical data tells a different story about long-term value:
If you try Duromine at $400 for three months, regain the weight, try again, regain again, and eventually switch to GLP-1 anyway, you have spent $800+ and a year of frustration before arriving at the treatment that works long-term.
Neither option is covered by standard health insurance or Medisave for weight management purposes in most cases.
Yes. Duromine (phentermine) remains widely available in Singapore through GP clinics and polyclinics. It is a prescription medication, so you need a doctor's consultation. It is typically easier to obtain than GLP-1 medications because more GPs are familiar with prescribing it. Duromine is available as slow-release capsules in 15 mg and 30 mg. Panbesy, an immediate-release version of phentermine, is also available.
This is not standard practice. Combining a sympathomimetic stimulant (Duromine) with a GLP-1 receptor agonist (Ozempic) has not been studied in clinical trials, and most doctors would not prescribe both simultaneously. If you are considering switching from one to the other, your doctor will manage the transition with an appropriate washout period. Do not take both without medical supervision.
Duromine's side effects tend to be stimulant-related: insomnia, dry mouth, increased heart rate, restlessness, and irritability. GLP-1 side effects are mostly gastrointestinal: nausea, reduced appetite, constipation, or diarrhoea. For most patients, GLP-1 side effects are milder and improve over the first few weeks as your body adjusts. Duromine's stimulant effects can persist throughout treatment. Read our full guide on managing GLP-1 side effects.
It might be. The key difference is sustainability. Duromine is limited to 12 weeks and works through stimulant-based appetite suppression that fades with tolerance. GLP-1 medications work through hormonal pathways that remain effective over months and years, without the tolerance issue. Many GLP-1 patients are former Duromine users who found that GLP-1 treatment produced lasting results where Duromine did not. However, individual responses vary, and your doctor can help set realistic expectations.
For a broader overview of all prescription weight loss options available in Singapore, see our guide to doctor-prescribed weight loss medications.
This article is for informational purposes only and does not constitute medical advice. Always consult your doctor before starting, stopping, or changing any medication. Individual results may vary. Trimly is a MOH-licensed telehealth clinic in Singapore (HCSA License R/25M0505/MDS/001/252).
Clinical trial results are based on controlled study conditions and may not reflect real-world outcomes. Weight loss results vary depending on individual factors including starting weight, adherence, diet, and exercise. The figures cited in this article come from specific trial populations and dosing regimens.